Martin Platten
Overview
Explore the profile of Martin Platten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
655
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gruell H, Gunst J, Cohen Y, Pahus M, Malin J, Platten M, et al.
Lancet Microbe
. 2022 May;
3(3):e203-e214.
PMID: 35544074
Background: The administration of broadly neutralising anti-HIV-1 antibodies before latency reversal could facilitate elimination of HIV-1-infected CD4 T cells. We tested this concept by combining the broadly neutralising antibody 3BNC117...
2.
Platten M, Nienhaus A, Peters C, Cranen R, Wisplinghoff H, Kersten J, et al.
Int J Environ Res Public Health
. 2022 Feb;
19(4).
PMID: 35206616
Health workers (HW) are at increased risk for SARS-CoV-2 infection. In order to monitor the infection dynamic on the basis of contact with patients, HW at the St. Antonius Hospital...
3.
Platten M, Hoffmann D, Grosser R, Wisplinghoff F, Wisplinghoff H, Wiesmuller G, et al.
Viruses
. 2021 Aug;
13(8).
PMID: 34452325
In their recent article published in Viruses, Michel Drancourt and colleagues [...].
4.
Stecher M, Schommers P, Kollan C, Stoll M, Kuhlendahl F, Stellbrink H, et al.
Infection
. 2021 Aug;
49(6):1365-1366.
PMID: 34346028
No abstract available.
5.
Platten M, Cranen R, Peters C, Wisplinghoff H, Nienhaus A, Bach A, et al.
Dtsch Med Wochenschr
. 2021 Jan;
146(5):e30-e38.
PMID: 33513626
Background: We assessed the prevalence of SARS-CoV-2 in the staff of a general hospital in North-Rhine-Westphalia in a cross-sectional study. Method: Employees (n = 1363) were offered a nasopharyngeal swab...
6.
Stecher M, Schommers P, Kollan C, Stoll M, Kuhlendahl F, Stellbrink H, et al.
Infection
. 2020 Jul;
48(5):723-733.
PMID: 32613529
Objective: Combination antiretroviral therapy (cART) has markedly increased survival and quality of life in people living with HIV. With the advent of new treatment options, including single-tablet regimens, durability and...
7.
Stecher M, Classen A, Klein F, Lehmann C, Gruell H, Platten M, et al.
Clin Infect Dis
. 2019 May;
70(7):1406-1417.
PMID: 31102444
Background: Safety and tolerability of analytical treatment interruptions (ATIs) as a vital part of human immunodeficiency virus type 1 (HIV-1) cure studies are discussed. We analyzed current evidence for the...
8.
Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, et al.
Infection
. 2019 Feb;
47(2):257.
PMID: 30805900
In this article the cooperating partners of the ClinSurv HIV cohort were not listed in the acknowledgements. The correct paragraph appears below.
9.
Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, et al.
Infection
. 2018 Nov;
47(2):247-255.
PMID: 30414065
Purpose: The aim of the study was to assess guideline adherence to combined antiretroviral therapy (ART) in the German ClinSurv HIV Cohort and the real-life impact of the Strategic Timing...
10.
Augustin M, Horn C, Koch J, de Silva U, Platten M, Nierhoff D, et al.
AIDS Res Hum Retroviruses
. 2018 Jul;
35(3):247-250.
PMID: 30019612
The gastrointestinal mucosa [gut-associated lymphoid tissue (GALT)] represents the largest site of chronic immune activation and HIV replication. Important cellular agents in the immunopathogenesis of an HIV infection are, in...